{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 322159605
| IUPAC_name = 1,8-dihydroxyanthracene-9,10-dione
| image = Dantron.svg
| image2 = 1,8-Dihydroxyanthraquinone-3D-balls.png
<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration = 口、直肠（[[灌肠_(医学)|灌肠]]）
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 117-10-2
| ATC_prefix = A06
| ATC_suffix = AB03
| ATC_supplemental = {{ATC|A06|AG03}}
| PubChem = 2950
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB04816
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2845
| NIAID_ChemDB = 001375
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = Z4XE6IBF3V
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D07107
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 3682
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 53418
<!--Chemical data-->
| C=14 | H=8 | O=4
| smiles = O=C2c1cccc(O)c1C(=O)c3c2cccc3O
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = QBPFLULOKWLNNW-UHFFFAOYSA-N
}}

'''丹蒽醌'''（又称'''柯嗪'''、'''1,8-二羟基蒽醌'''）是一种有机化合物，由[[蒽醌|蒽醌]]上1、8号位的两个氢原子被[[羟基|羟基]]取代而成。在一些国家，丹蒽醌可用作[[泻药|泻药]]。

== 应用 ==
在[[美国|美国]]，丹蒽醌由于被认定为[[致癌物质|致癌物质]]，因此不被使用。<ref>[[美國國家毒物計畫|美國國家毒物計畫]]网站上关于[https://ntp.niehs.nih.gov/ntp/roc/content/profiles/danthron.pdf 丹蒽醌的简介] {{Wayback|url=https://ntp.niehs.nih.gov/ntp/roc/content/profiles/danthron.pdf |date=20210318034916 }}</ref>

在[[英国|英国]]，丹蒽醌被认定为潜在致癌物质，仅限用于已被诊断为癌症晚期的患者，一般用于[[临终关怀|临终关怀]]，以抵消[[鸦片类药物|鸦片类药物]]造成的便秘。<ref name=BNF>{{Cite web |url=http://www.bnf.org/ |title=英国国家处方集网站 |access-date=2021-04-11 |archive-date=2021-04-27 |archive-url=https://web.archive.org/web/20210427213820/https://www.bnf.org/ }}</ref>

丹蒽醌可以口服，也可以单独或与其他泻药一起通过直肠给药。<ref>{{cite web |url=https://www.whocc.no/atc_ddd_index/?code=A06AG&showdescription=yes |title=A06AG Enemas |date=13 December 2018 |work=WHO Collaborating Centre for Drug Statistics Methodology |publisher=World Health Organization |access-date=17 March 2019 |archive-date=2021-04-11 |archive-url=https://web.archive.org/web/20210411104646/https://www.whocc.no/atc_ddd_index/?code=A06AG&showdescription=yes }}</ref>

== 副作用 ==
丹蒽醌最明显的副作用是会导致尿液呈红色。

==参见==
* {{link-en|大黄酸|Rhein (molecule)}}

==参考资料==
{{reflist}}

{{轻泻药}}

[[Category:IARC第2B类致癌物质|Category:IARC第2B类致癌物质]]
[[Category:轻泻药|Category:轻泻药]]
[[Category:二羟基蒽醌|Category:二羟基蒽醌]]